Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus

Cell Death and Disease

Volumn 5, Issue 10, 2014, Pages

  Liu, J Y ^a   Yao, J ^a   Li, X M ^a   Song, Y C ^a   Wang, X Q ^a   Li, Y J ^a   Yan, B ^a   Jiang, Q ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MALAT1 LONG NON-CODING RNA, MOUSE; MALAT1 LONG NONCODING RNA, RAT; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY; CELL LOSS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DEREGULATION; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RETINA BLOOD VESSEL; RETINA CELL; RETINITIS; UPREGULATION; ANGIOGENESIS; ANIMAL; CELL MOTION; CELL SURVIVAL; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; INFLAMMATION; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

MUS; RATTUS;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RETINAL VESSELS; RNA, LONG NONCODING; UP-REGULATION;

EID: 84925858306     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.466     Document Type: Article

References (23)

1. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2011; 29: 116-122.
2. Morita H, Nagai R. Retinopathy progression in type 2 diabetes. N Engl J Med 2010; 363: 2173-2174.
3. Hammes H-P, Feng Y, Pfister F, Brownlee M. Diabetic retinopathy: targeting vasoregression. Diabetes 2011; 60: 9-16.
4. Nguyen TT, Wang JJ, Wong TY. Retinal vascular changes in prediabetes and prehypertension new findings and their research and clinical implications. Diabetes Care 2007; 30: 2708-2715.
5. Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011; 52: 1156-1163.
6. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009; 10: 155-159.
7. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21: 354-361.
8. Morán I, Akerman I, van de Bunt M, Xie R, Benazra M, Nammo T et al. Human ß cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab 2012; 16: 435-448.
9. Tsai F-J, Yang C-F, Chen C-C, Chuang L-M, Lu C-H, Chang C-T et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet 2010; 6: e1000847.
10. Yan B, Tao ZF, Li XM, Zhang H, Yao J, Jiang Q. Aberrant expression of long noncoding RNAs in early diabetic retinopathy. Invest Ophthalmol Vis Sci 2014; 55: 941-951.
11. Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res 2011; 30: 343-358
12. Xu X-D, Li K-R, Li X-M, Yao J, Qin J, Yan B. Long non-coding RNAs: new players in ocular neovascularization. Mol Biol Rep 2014; 41: 4493-4505.
13. Bell RD, Long X, Lin M, Bergmann JH, Nanda V, Cowan SL et al. Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol 2014; 34: 1249-1259.
14. Leung A, Trac C, Jin W, Lanting L, Akbany A, Sætrom P et al. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res 2013; 113: 266-278.
15. Michalik KM, You X, Manavski Y, Doddaballapur A, Zornig M, Braun T et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 2014; 114: 1389-1397.
16. Congrains A, Kamide K, Katsuya T, Yasuda O, Oguro R, Yamamoto K et al. CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun 2012; 419: 612-616.
17. Lorenzen J, Kumarswamy R, Dangwal S, Thum T. MicroRNAs in diabetes and diabetes associated complications. RNA Biol 2012; 9: 820-827.
18. Hu Y, Chen Y, Ding L, He X, Takahashi Y, Gao Y et al. Pathogenic role of diabetes-induced PPAR-alpha down-regulation in microvascular dysfunction. Proc Natl Acad Sci USA 2013; 110: 15401-15406.
19. Gutschner T, Hammerle M, Diederichs S. MALAT1 - a paradigm for long noncoding RNA function in cancer. J Mol Med (Berl) 2013; 91: 791-801.
20. Qiu MT, Hu JW, Yin R, Xu L. Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol 2013; 34: 613-620.
21. Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J 2010; 429: 403-417.
22. Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 2012; 92: 689-737.
23. Xin X, Rodrigues M, Umapathi M, Kashiwabuchi F, Ma T, Babapoor-Farrokhran S et al. Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proc Natl Acad Sci USA 2013; 110: E3425-E3